RA Capital Management’s Peter Kolchinsky says the companies that survived the industry’s 2021 rout are thriving—and looking ...

XBI is a biotech-focused ETF offering equal-weight exposure to U.S. biotechnology companies. The SPDR S&P Biotech ETF tracks the performance of the S&P Biotechnology Select Industry Index. XBI ...

Nasdaq has long been the home for biotech companies, and this past January, National Biotechnology Month proved no different. The sector was active with five healthcare companies raising $800 million ...

Biotech stocks are emerging from a four-year slump. The SPDR S&P Biotech exchange-traded fund XBI, a proxy for the sector, is up 25% so far this year through Oct. 31, beating the S&P 500 SPX by 9 ...

This transcript was prepared by a transcription service. This version may not be in its final form and may be updated. Alex Ossola: U.S. hiring slowed in January, but remained solid in the last jobs ...

Tobi is a crypto writer at Investopedia. He aims to simplify the complex concepts of blockchain and cryptocurrencies for the masses. Julie Bang/ Investopedia More people need better medicines, and ...

AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Read more here.

Karen Marshall is the Executive Producer of GBH News' Morning Edition. Having alway dreamed of being an editor or writer, Karen got her start in radio at WROR in Boston as an intern, eventually ...

The companies Cogent Biosciences, Braveheart Bio, and AAVantgarde bagged the biggest biotech funding rounds overall in ...